New episode dropping Friday at 4:00pm EST. In this episode, we explore how ketamine, a dissociative anesthetic, is being investigated as a treatment for depression and related conditions. We discuss ketamine's role in promoting neuroplasticity — rewiring the brain at the microstructural level to help recovery from stress- and/or depression-induced pathology — and review the evidence from clinical trials, including a landmark 2023 meta-analysis. We will dive deep into the mechanisms of ketamine's neuroplastic potential in the brain what it means for the future of therapy.
Nick Sterling, MD, PhD
New episode dropping January 15.
Top 5 side effects of the GLP-1 receptor agonists... in the ER.
7 months ago | [YT] | 0
View 0 replies
Nick Sterling, MD, PhD
New episode dropping Friday at 4:00pm EST. In this episode, we explore how ketamine, a dissociative anesthetic, is being investigated as a treatment for depression and related conditions. We discuss ketamine's role in promoting neuroplasticity — rewiring the brain at the microstructural level to help recovery from stress- and/or depression-induced pathology — and review the evidence from clinical trials, including a landmark 2023 meta-analysis. We will dive deep into the mechanisms of ketamine's neuroplastic potential in the brain what it means for the future of therapy.
8 months ago | [YT] | 0
View 0 replies